Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jacksonville, FL
NPI
1801877576
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
915 W Monroe St Ste 200
Jacksonville, FL, 32204
Phone (904) 384-2240
Groups this clinician bills Medicare through
Medicare paid, 2024
$222K
5,077 services
Medicare patients, 2024
987
Average age 73
Drug cost, 2024
$3.7M
5,863 prescriptions
Company payments, 2025
$3,143
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khurram Wadud was code 99214 (office e&m - established), 1,443 times for 721 patients. In total Khurram Wadud billed 5,077 services in 23 codes, and Medicare paid $222K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,443 | 721 | $87.87 | $127K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 965 | 563 | $12.01 | $12K |
| 95251 Test - Miscellaneous | Office | 320 | 165 | $25.54 | $8,172 |
| 99213 Office E&M - Established | Office | 233 | 194 | $60.80 | $14K |
| 76536 Ultrasound - Nonspecific | Office | 199 | 184 | $77.46 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 192 | 91 | $61.04 | $12K |
| 99204 Office E&M - New | Office | 103 | 103 | $119.33 | $12K |
| 99203 Office E&M - New | Office | 92 | 92 | $76.11 | $7,002 |
| 96372 Injection Administration | Office | 71 | 11 | $9.83 | $698 |
| 95250 Test - Miscellaneous | Office | 52 | 50 | $110.11 | $5,725 |
| 10005 Other Organ Systems | Office | 27 | 25 | $104.41 | $2,819 |
| 99223 Hospital E&M - Initial | Facility | 23 | 23 | $136.02 | $3,129 |
By year: 2022 $192K for 7,272 services; 2023 $192K for 4,277 services; 2024 $222K for 5,077 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 204 | 189 | $2.99 | $611 |
| 80053 Clinical Chemistry | 153 | 146 | $10.54 | $1,612 |
| 84443 Clinical Chemistry | 151 | 144 | $16.77 | $2,532 |
| 83036 Blood Count | 140 | 132 | $9.69 | $1,357 |
| 80061 Clinical Chemistry | 133 | 127 | $13.36 | $1,777 |
| 82044 Clinical Chemistry | 92 | 87 | $6.22 | $572 |
| 82570 Clinical Chemistry | 92 | 87 | $5.17 | $476 |
| 84439 Clinical Chemistry | 69 | 68 | $9.00 | $621 |
| 84481 Clinical Chemistry | 54 | 51 | $16.91 | $913 |
| 82607 Clinical Chemistry | 35 | 35 | $15.06 | $527 |
Medicare prescription drug claims, 2024
In 2024, the drug Khurram Wadud prescribed most often to Medicare patients was Ozempic (Semaglutide), with 606 prescriptions and refills. In total Khurram Wadud wrote 5,863 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 606 | 1,140 | 162 | $1.1M |
| Levothyroxine Sodium Generic | 298 | 850 | 104 | $2,652 |
| Unithroid Levothyroxine Sodium | 251 | 683 | 75 | $15K |
| Mounjaro Tirzepatide | 209 | 345 | 59 | $365K |
| Synthroid Levothyroxine Sodium | 204 | 477 | 45 | $21K |
| Jardiance Empagliflozin | 189 | 437 | 71 | $249K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 177 | 481 | 80 | $20K |
| Metformin Hcl Generic | 168 | 466 | 57 | $977 |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 162 | 331 | 45 | $248K |
| Repaglinide Generic | 149 | 400 | 54 | $4,065 |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 145 | 227 | 33 | $186K |
| Farxiga Dapagliflozin Propanediol | 141 | 276 | 35 | $152K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 123 | 274 | 47 | $19K |
| Testosterone Cypionate Generic | 117 | 135 | 19 | $3,092 |
| Methimazole Generic | 113 | 312 | 37 | $853 |
Brand drugs: 3,447 claims; generic drugs: 1,792 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khurram Wadud $3,143 ($3,143 in general payments such as food, travel and fees) from 30 companies. The largest payer was Abbott Laboratories with $290.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 15 | $290 |
| Novo Nordisk Inc NVO | 20 | $287 |
| CeQur Corporation | 2 | $254 |
| Insulet Corporation PODD | 10 | $234 |
| Lilly USA, LLC LLY | 11 | $231 |
| Dexcom, Inc. DXCM | 10 | $231 |
| Sequel Med Tech, LLC | 6 | $223 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $173 |
| Sanofi-Aventis U.S. LLC SNY | 6 | $150 |
| Xeris Pharmaceuticals, Inc. | 7 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.